Publications by authors named "Pasi Halonen"

Claim this Profile
N
Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis.
Hanke L Matlung, Liane Babes, Xi Wen Zhao, Michel van Houdt, Louise W Treffers, Pasi Halonen

Cell Rep· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activity.
Amy J C Dohmen, Xiaohang Qiao, Anja Duursma, Ruud H Wijdeven, Cor Lieftink, Pasi Halonen

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Functional Genetic Screen Identifies the Phosphoinositide 3-kinase Pathway as a Determinant of Resistance to Fibroblast Growth Factor Receptor Inhibitors in FGFR Mutant Urothelial Cell Carcinoma.
Liqin Wang, Tonći Šuštić, Rodrigo Leite de Oliveira, Cor Lieftink, Pasi Halonen

Eur Urol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated in vivo genetic and pharmacologic screening identifies co-inhibition of EGRF and ROCK as a potential treatment regimen for triple-negative breast cancer.
Sedef Iskit, Cor Lieftink, Pasi Halonen, Aida Shahrabi, Patricia A Possik

Oncotarget· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of signalling cascades involved in red blood cell shrinkage and vesiculation.
Elena B Kostova, Boukje M Beuger, Thomas R L Klei, Pasi Halonen, Cor Lieftink

Biosci Rep· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Centmitor-1, a novel acridinyl-acetohydrazide, possesses similar molecular interaction field and antimitotic cellular phenotype as rigosertib, on 01910.Na.
Jenni H E Mäki-Jouppila, Leena J Laine, Jonathan Rehnberg, Elli Narvi, Pekka Tiikkainen, Pasi Halonen

Mol Cancer Ther· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VAV3 mediates resistance to breast cancer endocrine therapy.
Helena Aguilar, Ander Urruticoechea, Pasi Halonen, Kazuma Kiyotani, Taisei Mushiroda

Breast Cancer Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3.
Chong Sun, Sebastijan Hobor, Andrea Bertotti, Davide Zecchin, Sidong Huang, Pasi Halonen

Cell Rep· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase.
Elina Mattila, Heidi Marttila, Niko Sahlberg, Pekka Kohonen, Siri Tähtinen, Pasi Halonen

BMC Cancer· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
Kristiina Iljin, Kirsi Ketola, Paula Vainio, Pasi Halonen, Pekka Kohonen

Clin Cancer Res· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint.
Anna-Leena Salmela, Jeroen Pouwels, Asta Varis, Anu M Kukkonen, Pauliina Toivonen, Pasi K Halonen

Carcinogenesis· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer.
Mari Björkman, Kristiina Iljin, Pasi Halonen, Henri Sara, Elisa Kaivanto

Int J Cancer· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of active site mutations on the metal binding affinity, catalytic competence, and stability of the family II pyrophosphatase from Bacillus subtilis.
Pasi Halonen, Marko Tammenkoski, Laila Niiranen, Sauli Huopalahti, Alexey N Parfenyev

Biochemistry· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-turnover kinetics of Saccharomyces cerevisiae inorganic pyrophosphatase.
Pasi Halonen, Alexander A Baykov, Adrian Goldman, Reijo Lahti, Barry S Cooperman

Biochemistry· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis